Adlai Nortye (ANL) Operating Leases (2022 - 2025)

Adlai Nortye's (ANL) quarterly Operating Leases came in at $1.1 million in Q4 2025, up 165.18% year-on-year from $425000.0 in Q4 2024, and up 165.18% on a QoQ basis from $425000.0 in Q4 2024.

Adlai Nortye (ANL) Operating Leases (2022 - 2025) Analysis & Trends

Adlai Nortye (ANL) has 4 years of Operating Leases data on file, last reported at $1.1 million in Q4 2025.

  • On a quarterly basis, Operating Leases rose 165.18% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 165.18% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 165.18% from the prior year.
  • Operating Leases for Q4 2025 stood at $1.1 million, up from $425000.0 in the prior quarter.
  • Over the last five years, Operating Leases for ANL reached as high as $1.2 million in Q4 2022 and fell as low as $425000.0 in Q4 2024.
  • Historically, Operating Leases has averaged $814250.0 across 4 years, with a median of $798000.0 in 2023.
  • Across the five-year window, Operating Leases sank 62.06% in 2023 and surged 165.18% in 2025, its largest moves.
  • Year by year, Operating Leases stood at $1.2 million in 2022, then sank by 62.06% to $469000.0 in 2023, then retreated by 9.38% to $425000.0 in 2024, then jumped by 165.18% to $1.1 million in 2025.
  • Per Business Quant data, the three most recent Operating Leases figures were $1.1 million in Q4 2025, $425000.0 in Q4 2024, and $469000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Adlai Nortye 1.16 Bn 1.15 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.13 Mn
Dec 31, 2024 425,000.00
Dec 31, 2023 469,000.00
Dec 31, 2022 1.24 Mn